Exact Mass: 640.2897

N1,N5,N10-Tris-trans-p-coumaroylspermine

C37H44N4O6 (640.3261)

N1,N5,N10-Tris-trans-p-coumaroylspermine is found in herbs and spices. It is a constituent of Matricaria chamomilla (German chamomile). Constituent of Matricaria chamomilla (German chamomile). N1,N5,N10-Tris-trans-p-coumaroylspermine is found in herbs and spices.

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C33H53O10P (640.3376)

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Resolvin D5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0)

C33H53O10P (640.3376)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0), in particular, consists of one chain of one Resolvin D5 at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C33H53O10P (640.3376)

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)), in particular, consists of one chain of one octanoyl at the C-1 position and one chain of Protectin DX at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0)

C33H53O10P (640.3376)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0), in particular, consists of one chain of one Protectin DX at the C-1 position and one chain of octanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Alpindenoside B

C32H48O13 (640.3095)

Scupontin D

C32H48O13 (640.3095)

12-O-Methylnimbolinin B

C36H48O10 (640.3247)

Swietephragmin G

C34H40O12 (640.252)

Scortechinone S

C35H44O11 (640.2883)

Moluccensin A

C35H44O11 (640.2883)

Moluccensin F

C35H44O11 (640.2883)

Ixerisoside K

C31H44O14 (640.2731)

Crooksiine

C36H40N4O7 (640.2897)

Chenabinol methyl ether

C38H44N2O7 (640.3148)

(+)-thalirugine|Thalirugine

C38H44N2O7 (640.3148)

malavanin E

C35H44O11 (640.2883)

linifolin b

C36H48O10 (640.3247)

cucurbitacin E 2,16-diacetate

C36H48O10 (640.3247)

Trisaemulin BAB|Trisaemulin-BAB

C34H40O12 (640.252)

Furobinordentatin

C38H40O9 (640.2672)

cryptophycin-50

C34H41ClN2O8 (640.2551)

cryptophycin-40

C34H41ClN2O8 (640.2551)

Filixic acid ABB

C34H40O12 (640.252)

Myrsinoltype diterpene ester CPB51-719-1

C35H44O11 (640.2883)

SCHEMBL7530367

C34H40O12 (640.252)

(18R,19S)-phorbaside|phorbaside A

C33H49ClO10 (640.3014)

Norcimiciphytine

C36H40N4O7 (640.2897)

coronalactoside I

C32H48O13 (640.3095)

(1R,3E,8E,10R,13S)-9.10,13-tris(acetoxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl (2E)-3-phenylprop-2-enoate|(3E,8E)-9,10beta,13alpha-triacetoxy-2alpha,7beta,20-trihydroxy-5alpha-[(2E)-cinnamoyloxy]-3,8-secotaxa-3,8,11-triene

C35H44O11 (640.2883)

Agrimol F

C34H40O12 (640.252)

Filixic acid pbp

C34H40O12 (640.252)

1beta,2beta,3,beta4,beta,5beta,7alpha-hexaol-spirost-25(27)-en-6-one-4-O-beta-D-xylopyranoside|tupisteroide A

C32H48O13 (640.3095)

(2E,5E)-7-hydroperoxy-3,7-dimethyl-2,5-octadienyl-O-(alpha-L-rhamnopyranosyl)-(1??3?)-(4??-O-trans-p-coumaroyl)-beta-D-glucopyranoside|liguroside A

C31H44O14 (640.2731)

3beta-benzoyloxy-5alpha,8alpha-diacetoxy-15beta-hydroxy-7beta-isobutanoyloxyjatropha-6(17),11E-diene-9,14-dione

C35H44O11 (640.2883)

3beta-benzoyloxy-7beta-n-butanoyloxy-5alpha,8alpha-diacetoxy-15beta-hydroxyjatropha-6(17),11E-diene-9,14-dione

C35H44O11 (640.2883)

pierisformotoxin A|rel-(3aR,4S,4aS,7S,8R,9S,9aR,10R,11S,11aR,12S)-8,9,10,11-tetrakis(acetyloxy)decahydro-4-hydroxy-11a-(1-hydroxy-1-methylethyl)-4,8-dimethyl-12-(1-oxopropoxy)-4H-7,9a-methanoheptaleno[3,2-b]furan-2(3H)-one

C31H44O14 (640.2731)

(2S,3S,4R,5R,7R,9S,11S,15R)-5,15-diacetoxy-3,7-dibenzoyloxy-14-oxolathyra-6(17),12E-diene|euphorbia factor L2

C39H44O8 (640.3036)

pierisformotoxin B|rel-(3aR,4S,4aS,7S,8R,9S,9aR,10R,11S,11aR,12S)-8,9,11,12-tetrakis(acetyloxy)decahydro-4-hydroxy-11a-(1-hydroxy-1-methylethyl)-4,8-dimethyl-10-(1-oxopropoxy)-4 H-7,9a-methanoheptaleno[3,2-b]furan-2(3H)-one

C31H44O14 (640.2731)

1alpha-acetoxy-6beta,9beta,15-tribenzoyloxy-beta-dihydroagarofuran

C38H40O9 (640.2672)

CHEMBL2337115

C36H36N2O9 (640.2421)

Trisabbreviatain BBB

C34H40O12 (640.252)

4,5-dioxo-4,5-secopheophorbide a methyl ester

C36H40N4O7 (640.2897)

6-Acetoxy-1,8,9-tribenzoyloxydihydro-alpha-agarofuran

C38H40O9 (640.2672)

kidjoranin 3-O-beta-D-digitoxopyranoside|kidjoranin 3-O-beta-digitoxopyranoside

C36H48O10 (640.3247)

4,5-Dioxo-4,5-secophaeophorbide b

C35H36N4O8 (640.2533)

1-Acetoxy-2,6,9-tribenzoyloxydihydro-alpha-agarofuran

C38H40O9 (640.2672)

violide K

C32H48O13 (640.3095)

2-[4-(beta-D-glucopyranosyloxy)-3-hydroxy-2,5-bis(3-methylbut-2-en-1-yl)phenyl]-2-[(3-hydroxy-5-methoxy-3-methyl-5-oxopentanoyl)oxy]acetic acid|sabphenoside C

C31H44O14 (640.2731)

cryptophycin-27

C34H41ClN2O8 (640.2551)

(+)-maroumine

C37H40N2O8 (640.2785)

Phe Lys Glu Ala Phe

C32H44N6O8 (640.322)

Ingol 7,8,12-triacetate 3-(4-methoxyphenyl)acetate

C35H44O11 (640.2883)

oxetanabeodendroidin X

C35H44O11 (640.2883)

Cys Phe Trp Trp

C34H36N6O5S (640.2468)

Cys Trp Phe Trp

C34H36N6O5S (640.2468)

Cys Trp Trp Phe

C34H36N6O5S (640.2468)

Phe Cys Trp Trp

C34H36N6O5S (640.2468)

Phe Trp Cys Trp

C34H36N6O5S (640.2468)

Phe Trp Trp Cys

C34H36N6O5S (640.2468)

His Ile Trp Trp

C34H40N8O5 (640.3122)

His Leu Trp Trp

C34H40N8O5 (640.3122)

His Trp Ile Trp

C34H40N8O5 (640.3122)

His Trp Leu Trp

C34H40N8O5 (640.3122)

His Trp Trp Ile

C34H40N8O5 (640.3122)

His Trp Trp Leu

C34H40N8O5 (640.3122)

Ile His Trp Trp

C34H40N8O5 (640.3122)

Ile Trp His Trp

C34H40N8O5 (640.3122)

Ile Trp Trp His

C34H40N8O5 (640.3122)

Leu His Trp Trp

C34H40N8O5 (640.3122)

Leu Trp His Trp

C34H40N8O5 (640.3122)

Leu Trp Trp His

C34H40N8O5 (640.3122)

Ser Trp Trp Tyr

C34H36N6O7 (640.2645)

Ser Trp Tyr Trp

C34H36N6O7 (640.2645)

Ser Tyr Trp Trp

C34H36N6O7 (640.2645)

Trp Cys Phe Trp

C34H36N6O5S (640.2468)

Trp Cys Trp Phe

C34H36N6O5S (640.2468)

Trp Phe Cys Trp

C34H36N6O5S (640.2468)

Trp Phe Trp Cys

C34H36N6O5S (640.2468)

Trp His Ile Trp

C34H40N8O5 (640.3122)

Trp His Leu Trp

C34H40N8O5 (640.3122)

Trp His Trp Ile

C34H40N8O5 (640.3122)

Trp His Trp Leu

C34H40N8O5 (640.3122)

Trp Ile His Trp

C34H40N8O5 (640.3122)

Trp Ile Trp His

C34H40N8O5 (640.3122)

Trp Leu His Trp

C34H40N8O5 (640.3122)

Trp Leu Trp His

C34H40N8O5 (640.3122)

Trp Ser Trp Tyr

C34H36N6O7 (640.2645)

Trp Ser Tyr Trp

C34H36N6O7 (640.2645)

Trp Trp Cys Phe

C34H36N6O5S (640.2468)

Trp Trp Phe Cys

C34H36N6O5S (640.2468)

Trp Trp His Ile

C34H40N8O5 (640.3122)

Trp Trp His Leu

C34H40N8O5 (640.3122)

Trp Trp Ile His

C34H40N8O5 (640.3122)

Trp Trp Leu His

C34H40N8O5 (640.3122)

Trp Trp Ser Tyr

C34H36N6O7 (640.2645)

Trp Trp Tyr Ser

C34H36N6O7 (640.2645)

Trp Tyr Ser Trp

C34H36N6O7 (640.2645)

Trp Tyr Trp Ser

C34H36N6O7 (640.2645)

Tyr Ser Trp Trp

C34H36N6O7 (640.2645)

Tyr Trp Ser Trp

C34H36N6O7 (640.2645)

Tyr Trp Trp Ser

C34H36N6O7 (640.2645)

FKEAF

C32H44N6O8 (640.322)

5-Methyltetrahydropteroyltri-L-glutamate

C25H36N8O12 (640.2453)

N1,N5,N10-Tris-trans-p-coumaroylspermine

C37H44N4O6 (640.3261)

PHHdiA-PG

C29H53O13P (640.3224)

catechin(3,4,5,7-tetraacetate)-3-dodecanoate

C35H44O11 (640.2883)

Cyclo(-Gly-Arg-Gly-Asp-Ser-Pro-Ala)

C25H40N10O10 (640.2929)

Ociltide

C31H40N6O7S (640.2679)

2-[2-[2-chloro-3-[2-(3-methyl-1,3-benzothiazol-3-ium-2-yl)ethenyl]cyclopent-2-en-1-ylidene]ethylidene]-3-methyl-1,3-benzothiazole

C38H41ClN2O3S (640.2526)

Fmoc-Lys(Mtt)-OH

C41H40N2O5 (640.2937)

Fmoc-Lys(MMt)-OH

C41H40N2O5 (640.2937)

3-butyl-2-[3-(3-butyl-1,1-dimethylbenzo[e]indol-3-ium-2-yl)prop-2-enylidene]-1,1-dimethylbenzo[e]indole,perchlorate

C39H45ClN2O4 (640.3068)

N,N,N,N-Tetraphenyl-1,1:4,1:4,1-quaterphenyl-4,4-di amine

C48H36N2 (640.2878)

Buthyltin Mercaptide

C28H56O4S2Sn (640.2642)

2,2-Methylene Bis[Ranitidine]

C27H44N8O6S2 (640.2825)

R-3,3-di-9-phenanthrenyl-1,1-Binaphthalene]-2,2-diol

C48H32O2 (640.2402)

tetra-(3-pyridylphenyl)ethylene

C46H32N4 (640.2627)

diisooctyl 2,2-[(dibutylstannylene)bis(thio)]diacetate

C28H56O4S2Sn (640.2642)

Dansyl-NECA

C30H40N8O6S (640.2791)

Thiomarinol A

C30H44N2O9S2 (640.2488)

An organosulfur heterocyclic compound produced by a marine bacterium Alteromonas rava and has been shown to exhibit antibacterial activity against Gram-positive and Gram-negative bacteria.

5-carboxysalinisporamycin A

C34H42NO11- (640.2758)

3-[(21S,22S)-12-(dihydroxymethyl)-26-ethyl-4-hydroxy-16-(1-hydroxyethyl)-17,19,21-trimethyl-11-(2-methylpropyl)-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C37H44N4O6 (640.3261)

PA(8:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))

C33H53O10P (640.3376)

PA(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/8:0)

C33H53O10P (640.3376)

PA(8:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))

C33H53O10P (640.3376)

PA(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/8:0)

C33H53O10P (640.3376)

orbiculin G

C38H40O9 (640.2672)

A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by an acetoxy group at position 1 and benzoyloxy groups at positions 2, 6 and 9 (the 1beta,2beta,6alpha,9alpha stereoisomers). Isolated from the roots of Celastrus orbiculatus and Microtropis fokienensis and exhibits cytotoxic and antitubercular properties.

Euphorbia diterpenoid 1

C35H44O11 (640.2883)

A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against prolyl endopeptidase (EC 3.4.21.26).

Kidjoranin-3-O-beta-digitoxopyranoside

C36H48O10 (640.3247)

A steroid glycoside isolated from the roots of Cynanchum auriculatum and has been shown to exhibit cytotoxicity against human tumour cell lines. Kidjoranin-3-O-beta-digitoxopyranoside is a steroid glycoside isolated from the roots of Cynanchum auriculatum and has been shown to exhibit cytotoxicity against human tumour cell lines. It has a role as a metabolite and an antineoplastic agent. It is a 17beta-hydroxy steroid, a cinnamate ester, a methyl ketone, a deoxy hexoside, a steroid ester, a steroid saponin and a tertiary alpha-hydroxy ketone. It derives from a hydride of a pregnane.

3-oxo-5alpha-androstan-17beta-yl 2-O-beta-D-glucopyranuronosyl-beta-D-glucopyranosiduronate

C31H44O14-2 (640.2731)

Ac-Gln-D-Phe-His-D-Pro-betaAla

C30H40N8O8 (640.2969)

1-(4-fluorophenyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea

C37H41FN4O5 (640.3061)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H53O10P (640.3376)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] nonanoate

C29H52O15 (640.3306)

[2-Heptanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropyl] heptanoate

C29H52O15 (640.3306)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] octanoate

C29H52O15 (640.3306)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] dodecanoate

C29H52O15 (640.3306)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] undecanoate

C29H52O15 (640.3306)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] decanoate

C29H52O15 (640.3306)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-heptadec-9-enoate

C29H53O13P (640.3224)

[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate

C29H53O13P (640.3224)

[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C29H53O13P (640.3224)

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-pentadec-9-enoate

C29H53O13P (640.3224)

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate

C29H53O13P (640.3224)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C33H53O10P (640.3376)

[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (Z)-octadec-9-enoate

C29H53O13P (640.3224)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C33H53O10P (640.3376)

SMGDG O-20:2;O

C29H52O13S (640.3128)

SQDG 20:1;O

C29H52O13S (640.3128)

PA 18:3/12:3;O2

C33H53O10P (640.3376)

PA 18:4/11:3;O3

C32H49O11P (640.3012)

PA 18:4/12:2;O2

C33H53O10P (640.3376)

PA 22:4/7:3;O3

C32H49O11P (640.3012)

PA 22:4/8:2;O2

C33H53O10P (640.3376)

PA 22:5/7:2;O3

C32H49O11P (640.3012)

PA 22:5/8:1;O2

C33H53O10P (640.3376)

PA 29:7;O3

C32H49O11P (640.3012)

PA 30:6;O2

C33H53O10P (640.3376)

LPGP 22:4

C28H50O12P2 (640.2777)

PG 16:0/7:2;O3

C29H53O13P (640.3224)

PG 18:4/8:3;O

C32H49O11P (640.3012)

PG 20:5/6:2;O

C32H49O11P (640.3012)

PG 22:6/4:1;O

C32H49O11P (640.3012)

PG 26:7;O

C32H49O11P (640.3012)

PI O-20:2;O

C29H53O13P (640.3224)

PI P-16:0/4:1;O

C29H53O13P (640.3224)

LPI 20:2;O

C29H53O13P (640.3224)

PI 14:1/5:1;O

C28H49O14P (640.286)

PI 19:2;O

C28H49O14P (640.286)

PI 16:0/4:1

C29H53O13P (640.3224)

PI 16:1/4:0

C29H53O13P (640.3224)

PI 18:1/2:0

C29H53O13P (640.3224)

PI 20:1

C29H53O13P (640.3224)

PI 2:0_18:1

C29H53O13P (640.3224)

ST 25:4;O8;GlcA

C31H44O14 (640.2731)

ST 26:3;O7;GlcA

C32H48O13 (640.3095)

ST 26:4;O8;Hex

C32H48O13 (640.3095)

6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

(1s,4s,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

(1s,2r,5r,6r,13r,14s,15s,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

8-{[(2e,4r)-4-[(2s,3r,4r,5s)-3,4-dihydroxy-5-[(2e,4r,5s)-5-hydroxy-4-methylhex-2-en-1-yl]oxan-2-yl]-4-hydroxy-3-methylbut-2-enoyl]oxy}-n-{5-hydroxy-[1,2]dithiolo[4,3-b]pyrrol-6-yl}octanimidic acid

C30H44N2O9S2 (640.2488)

(2z)-4-[(1r,2r,7s,14s,15s,16s,18s)-11-hydroxy-10-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5r,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

(3s,6r,10r,13e,16s)-10-[(3-chloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

(1s,4r,5r,10r,12s,14r,15s,16r,18r,19s,20r,22s)-5-(furan-3-yl)-15,16-dihydroxy-19-(2-methoxy-2-oxoethyl)-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-22-yl (2e)-2-methylbut-2-enoate

C34H40O12 (640.252)

4-[(2s,6as,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

(1s,2r,5s,6s,7s,9r,12r)-5-(acetyloxy)-12-(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C38H40O9 (640.2672)

(4r,5r,14r,16r,18r,19s,20r,22s)-5-(furan-3-yl)-15,16-dihydroxy-19-(2-methoxy-2-oxoethyl)-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-22-yl (2e)-2-methylbut-2-enoate

C34H40O12 (640.252)

9-{14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl}-8-hydroxy-7-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6(11),7,9-tetraen-18-one

C36H40N4O7 (640.2897)

5-(acetyloxy)-12-(benzoyloxy)-6-[(benzoyloxy)methyl]-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C38H40O9 (640.2672)

6α-acetoxy-1β,8β,9β-tribenzoyloxy-β-dihydro-agarofuran

C38H40O9 (640.2672)

{"Ingredient_id": "HBIN012191","Ingredient_name": "6\u03b1-acetoxy-1\u03b2,8\u03b2,9\u03b2-tribenzoyloxy-\u03b2-dihydro-agarofuran","Alias": "NA","Ingredient_formula": "C38H40O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "292","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,2r,5r,6r,13r,14s,15s,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

(3s,6's,7r)-5-[(3s,6's,7r)-7-(acetyloxy)-6',7-dimethyl-6,8-dioxo-1,4-dihydrospiro[2-benzopyran-3,2'-oxan]-5-ylidene]-6',7-dimethyl-6,8-dioxo-1,4-dihydrospiro[2-benzopyran-3,2'-oxan]-7-yl acetate

C34H40O12 (640.252)

3-(8-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl)-5h-furan-2-one

C32H48O13 (640.3095)

1-(3,4-dihydroxyphenyl)-7-hydroxy-n-[2-(4-hydroxyphenyl)ethyl]-3-{[2-(4-hydroxyphenyl)ethyl]carbamoyl}-6,8-dimethoxy-1,2-dihydronaphthalene-2-carboximidic acid

C36H36N2O9 (640.2421)

5-(acetyloxy)-7,12-bis(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl benzoate

C38H40O9 (640.2672)

8-{[(2e)-4-{3,4-dihydroxy-5-[(2e)-5-hydroxy-4-methylhex-2-en-1-yl]oxan-2-yl}-4-hydroxy-3-methylbut-2-enoyl]oxy}-n-{5-hydroxy-[1,2]dithiolo[4,3-b]pyrrol-6-yl}octanimidic acid

C30H44N2O9S2 (640.2488)

(1s)-1-{[4-(5-{[(1s)-7-hydroxy-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}-2-methoxyphenoxy)phenyl]methyl}-6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-5-ol

C38H44N2O7 (640.3148)

(1r,2r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17,19-bis(acetyloxy)-8-(furan-3-yl)-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl (2e)-2-methylbut-2-enoate

C36H48O10 (640.3247)

(1r)-5-(4-{[(1r)-6-hydroxy-7-methoxy-8-[(6-methoxy-2-methyl-1-oxo-3,4-dihydroisoquinolin-7-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-4-methoxycyclohexa-2,4-diene-1-carbaldehyde

C37H40N2O8 (640.2785)

(13e)-10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(3-phenyloxiran-2-yl)methyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

(1r,2r,4r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17,19-bis(acetyloxy)-8-(furan-3-yl)-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-12-yl (2e)-2-methylbut-2-enoate

C36H48O10 (640.3247)

5-[7-(acetyloxy)-6',7-dimethyl-6,8-dioxo-1,4-dihydrospiro[2-benzopyran-3,2'-oxan]-5-ylidene]-6',7-dimethyl-6,8-dioxo-1,4-dihydrospiro[2-benzopyran-3,2'-oxan]-7-yl acetate

C34H40O12 (640.252)

1-acetyl-7-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3a,3b-trihydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl 3-phenylprop-2-enoate

C36H48O10 (640.3247)

(1s,2r,3s,4s,7s,8z,10s,11r,12r,13s,16r,17s)-2,12-bis(acetyloxy)-3,4,11,16,17-pentahydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-8,14-dien-10-yl octanoate

C32H48O13 (640.3095)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,6as)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-3-(2-methylpropyl)-16-[1-(3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

methyl 2-[(1s,2s,4ar,5r,8s,8as)-1,8-dihydroxy-5-{[(2r)-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-2-yl]prop-2-enoate

C31H44O14 (640.2731)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-5,7-bis(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C38H40O9 (640.2672)

4-(8-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl)-5h-furan-2-one

C32H48O13 (640.3095)

5-[4-({6-hydroxy-7-methoxy-8-[(6-methoxy-2-methyl-1-oxo-3,4-dihydroisoquinolin-7-yl)oxy]-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl}methyl)phenoxy]-4-methoxycyclohexa-2,4-diene-1-carbaldehyde

C37H40N2O8 (640.2785)

(2s)-4-[(1r,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3as,5s,6ar)-5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl (3s)-3-(acetyloxy)butanoate

C32H48O13 (640.3095)

(1s,2r,5s,6s,7r,8r,9r,12r)-12-(acetyloxy)-5,7-bis(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C38H40O9 (640.2672)

10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[(3-phenyloxiran-2-yl)methyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

4-[(2r,6as,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

9,10,13-tris(acetyloxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl 3-phenylprop-2-enoate

C35H44O11 (640.2883)

9-{14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl}-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

(1s,2r,3e,5r,7s,8e,10s,13r)-9,10,13-tris(acetyloxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-5-yl (2e)-3-phenylprop-2-enoate

C35H44O11 (640.2883)

12-(acetyloxy)-5,7-bis(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl benzoate

C38H40O9 (640.2672)

(1s,2r,5r,6r,13r,14s,15r,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

10-[(3-chloro-4-hydroxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-[1-(3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

2-(4-{[(1s)-7-[(6,7-dimethoxy-2-methyl-3,4-dihydro-1h-isoquinolin-8-yl)oxy]-6-methoxy-2-methyl-3,4-dihydro-1h-isoquinolin-1-yl]methyl}phenoxy)-4-(methoxymethyl)phenol

C38H44N2O7 (640.3148)

(1s,2r,5s,6s,13s,14r,17r,18s)-6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

methyl 2-(1,8-dihydroxy-5-{[2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-4a-methyl-8-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-octahydronaphthalen-2-yl)prop-2-enoate

C31H44O14 (640.2731)

4-[(2r,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

(1s,2s,15r,17s)-13,19-dihydroxy-3,3,29,29-tetramethyl-6,26-bis(2-methylbut-3-en-2-yl)-4,8,16,24,28-pentaoxaheptacyclo[15.12.0.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²⁷.0²⁰,²⁵]nonacosa-5(14),6,10,12,18(27),19,21,25-octaene-9,23-dione

C38H40O9 (640.2672)

(1s,3ar,3bs,7s,9ar,9br,11r,11as)-1-acetyl-7-{[(2r,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3a,3b-trihydroxy-9a,11a-dimethyl-2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-11-yl (2e)-3-phenylprop-2-enoate

C36H48O10 (640.3247)

(3s,6r,10r,13e,16s)-10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-6-methyl-3-(2-methylpropyl)-16-{[(2r,3r)-3-phenyloxiran-2-yl]methyl}-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

(3s,10r,13e,16s)-10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-3-(2-methylpropyl)-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

3-[(2r,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

4-[11-hydroxy-10-(2-hydroxy-3-methylbut-3-en-1-yl)-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

(1s,2r,5r,6r,13r,14s,15r,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-13-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-14-yl 2-methylpropanoate

C35H44O11 (640.2883)

(1s,4r,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-8-hydroxy-7-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6(11),7,9-tetraen-18-one

C36H40N4O7 (640.2897)

10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-6-methyl-16-[1-(3-phenyloxiran-2-yl)ethyl]-3-propyl-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

(2z)-4-[(1r,2r,7r,14s,15s,16s,18s)-11-hydroxy-10-(2-hydroxy-3-methylbut-3-en-1-yl)-15,16-dimethoxy-6,6,7,20,20-pentamethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10-trien-18-yl]-2-methylbut-2-enoic acid

C35H44O11 (640.2883)

4-[(2s,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

4-[8-(acetyloxy)-3-hydroxy-5-{5-hydroxy-hexahydrofuro[2,3-b]furan-2-yl}-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethoxy]-4-oxobutan-2-yl 3-(acetyloxy)butanoate

C32H48O13 (640.3095)

(1s,2r,5s,6s,13s,14r,17r,18s)-6-(furan-3-yl)-17-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-13-yl 2-methylpropanoate

C35H44O11 (640.2883)

6-(furan-3-yl)-13-hydroxy-18-(2-methoxy-2-oxoethyl)-1,5,15-trimethyl-14-[(2-methylpropanoyl)oxy]-8,12-dioxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadec-10-en-17-yl 2-methylpropanoate

C35H44O11 (640.2883)

1-(2-{[2-(acetyloxy)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(4-hydroxyphenyl)butanoyl)-n-(5-carbamimidamido-1-hydroxypentan-2-yl)pyrrolidine-2-carboximidic acid

C32H44N6O8 (640.322)

1-{3-[(3-acetyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-5-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-2,4,6-trihydroxyphenyl}butan-1-one

C34H40O12 (640.252)

(1s,4r,12r,16s)-9-[(5r,9r,16r)-14,16-dihydroxy-6-methyl-2-oxo-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-10,12,14-trien-9-yl]-7-hydroxy-8-methoxy-5-methyl-17-oxa-5,15-diazahexacyclo[13.4.3.0¹,¹⁶.0⁴,¹².0⁶,¹¹.0¹²,¹⁶]docosa-2,6,8,10-tetraen-18-one

C36H40N4O7 (640.2897)

5-(furan-3-yl)-15,16-dihydroxy-19-(2-methoxy-2-oxoethyl)-4,12,18,20-tetramethyl-7-oxo-6,11,13,21-tetraoxaheptacyclo[10.8.1.1¹⁵,¹⁸.0¹,¹⁰.0⁴,⁹.0¹⁰,¹⁴.0¹⁶,²⁰]docos-8-en-22-yl 2-methylbut-2-enoate

C34H40O12 (640.252)

(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,8,9-tris(acetyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-13-yl 2-(4-methoxyphenyl)acetate

C35H44O11 (640.2883)

13,19-dihydroxy-3,3,29,29-tetramethyl-6,26-bis(2-methylbut-3-en-2-yl)-4,8,16,24,28-pentaoxaheptacyclo[15.12.0.0²,¹⁵.0⁵,¹⁴.0⁷,¹².0¹⁸,²⁷.0²⁰,²⁵]nonacosa-5(14),6,10,12,18(27),19,21,25-octaene-9,23-dione

C38H40O9 (640.2672)

(3s,6r,10r,13e,16s)-10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-6-methyl-16-[(1s)-1-[(2r,3r)-3-phenyloxiran-2-yl]ethyl]-3-propyl-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)

(1r,3r,4s,5r,6s,7s,9r,10s,11s,12s,13s,14s,15r,23s,25r)-3,10,11-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-12-yl benzoate

C36H48O10 (640.3247)

3,10,11-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-12-yl benzoate

C36H48O10 (640.3247)

3-[(2s,6ar,8s,10as)-8-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-7,7,10a-trimethyl-1h,2h,4h,5h,6h,6ah,8h,9h,10h-naphtho[2,1-c]pyran-2-yl]-5h-furan-2-one

C32H48O13 (640.3095)

(3s,10r,13e,16s)-10-[(3-chloro-4-methoxyphenyl)methyl]-9,12-dihydroxy-3-(2-methylpropyl)-16-[(1r)-1-[(2r,3s)-3-phenyloxiran-2-yl]ethyl]-1,4-dioxa-8,11-diazacyclohexadeca-8,11,13-triene-2,5-dione

C34H41ClN2O8 (640.2551)